نتایج جستجو برای: tablet

تعداد نتایج: 32790  

Journal: :European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 2013
J Vercruysse U Delaet I Van Assche P Cappuyns F Arata G Caporicci T De Beer J P Remon C Vervaet

The aim of this study was to investigate the process transfer of a commercially available product from the current batch fluid bed granulation and drying production method to an innovative continuously operating "from powder to tablet" production line using twin screw granulation as an intermediate granulation step. By monitoring process outcomes (torque, water temperature at the granulator jac...

Journal: :Allergy 2015
J Maloney S Durham D Skoner R Dahl A Bufe D Bernstein K Murphy S Waserman G Berman M White A Kaur H Nolte

BACKGROUND Patients with asthma may be more susceptible to adverse events (AEs) with sublingual immunotherapy tablet (SLIT-tablet) treatment, such as severe systemic reactions and asthma-related events. Using data from eight trials of grass SLIT-tablet in subjects with allergic rhinitis with/without conjunctivitis (AR/C), AE frequencies were determined in adults and children with and without re...

2016

Nifedipine Extended-release Tablet depends for its action on the existence of an osmotic gradient between the contents of the tablet core and fluid in the GI tract. Drug delivery is essentially constant as long as the osmotic gradient remains constant, and then gradually falls to zero. Upon swallowing, the biologically inert components of the tablet remain intact during GI transit and are elimi...

2013
Daniele Zanni Leena Arhippainen

We describe our work-in-progress on deriving guidelines for porting tablet interfaces onto wall-sized touchscreen displays. As the first case study we have ported the 3D user interface of a virtual city model originally designed for a single-user tablet display. We discuss the challenges encountered and solutions adopted in the process of converting the 3D interface originally designed for a pr...

Journal: :Pain medicine 2010
Perry G Fine Arvind Narayana Steven D Passik

BACKGROUND Opioids can be a safe and effective option for carefully selected patients with a structured treatment program that includes consistent monitoring. However, the benefits and risks of opioid therapy for patients with chronic pain, and society as a whole, have been sharply debated. A key component of this debate has involved the administration of rapid-onset opioids for the management ...

2013
Giorgio L Colombo Sergio Di Matteo Franco Maggiolo

BACKGROUND The aim of this study was to assess the economic value of a reduced number of pills in patients infected with the immunodeficiency virus (HIV) and on highly active antiretroviral therapy by a cost-effectiveness model. METHODS An incremental cost-effectiveness analysis of efavirenz, tenofovir, and emtricitabine (TDF-FTC-EFV) as a single-tablet regimen versus a multipill regimen, wit...

Journal: :Antiviral therapy 2014
Elizabeth G Rhee Matthew L Rizk Diana M Brainard Isaias N Gendrano Bo Jin Larissa A Wenning John A Wagner Marian Iwamoto

BACKGROUND Raltegravir is an HIV-1 integrase inhibitor approved for use in adults, children and infants ≥4 weeks of age. As alternatives to the original film-coated tablet, a chewable ethylcellulose (EC) tablet and oral granules for suspension (GFS) have been developed for use in children. The purpose of this study was to evaluate these formulations in adults prior to use in paediatric studies....

2017
Mahta Karimpoor Nathan W. Churchill Fred Tam Corinne E. Fischer Tom A. Schweizer Simon J. Graham

The Trail Making Test (TMT) is widely used for assessing executive function, frontal lobe abilities, and visual motor skills. Part A of this pen-and-paper test (TMT-A) involves linking numbers randomly distributed in space, in ascending order. Part B (TMT-B) alternates between linking numbers and letters. TMT-B is more demanding than TMT-A, but the mental processing that supports the performanc...

2009

Altace Tablets (ramipril) are supplied as tablets for oral administration containing 1.25 mg, 2.5 mg, 5 mg and 10 mg of ramipril. The inactive ingredients present are calcium sulphate dihydrate, pregelatinized starch, sodium bicarbonate, and sodium stearyl fumarate. The 2.5 mg tablet contains yellow iron oxide and FD&C yellow #6, the 5 mg tablet contains FD&C yellow #6 and FD&C red #40, and the...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید